Chromocell Appoints Frank Knuettel As CEO

Mar 18, 2024•over 1 year ago

Position

Chief Executive Officer

Company

Chromocell Therapeutics Corp

Frank Knuettel

North BrunswickTherapeuticsBiotechnologyHealth Care

Description

Chromocell Therapeutics Corp. appoints interim CEO Frank Knuettel as the permanent CEO. Frank Knuettel will continue to also serve as the Company’s CFO for the near future.

Company Information

Company

Chromocell Therapeutics Corp

Location

North Brunswick, New Jersey, United States

About

Chromocell Therapeutics Corporation is a clinical-stage biotechnology company focused on developing and commercializing novel, non-opioid, non-addictive, therapeutics to alleviate pain and other associated medical conditions. The Company’s initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain and acute eye pain. Chromocell Therapeutics portfolio also includes several novel sublingual and intranasal single-use, disposable spray devices that are intended to treat various conditions including mild to moderate pain, acute migraine and nausea and vomiting associated with chemotherapy and surgery or anesthesia.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months